Profile
| Metric | Value |
|---|---|
| Full Name | Warby Parker Inc. |
| Ticker | NYSE: WRBY |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | warbyparker.com |
| Employees | 2,218 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $22.62 | |
| Price, 1D Change | +3.81% | |
| Market Cap | $3B | |
| - | ||
| PE Ratio | 5,952.63 | |
| Beta | 1.72 | |
| Revenue | $771M | |
| Revenue, 1Y Change | +15.16% | |
| EPS | -$0.17 | |
| EPS, 1Y Change | +68.54% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$0.17 | |
| EPS Estimate | $0.37 | |
| EPS Est. Change | +318.12% | |
| Revenue | $771.32M | |
| Revenue Estimate | $873.17M | |
| Revenue Est. Change | +13.21% | |
| Current Price | $22.62 | |
| Price Target | - | $27.00 |
| Price Tgt. Change | - | +19.36% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.12 | -$0.54 | -548.67% | |
| $0.23 | -$0.17 | -172.21% | |
| $0.37 | N/A | +318.12% | |
| $0.49 | N/A | +389.67% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $668.94M | $669.77M | +0.12% | |
| $767.79M | $771.32M | +0.46% | |
| $873.17M | N/A | +13.21% | |
| $987.69M | N/A | +28.05% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -10.77% | |
| Price, 3Y | +67.68% | |
| Market Cap, 1Y | -9.80% | |
| Market Cap, 3Y | +77.60% | |
| Revenue, 1Y | +15.16% | |
| Revenue, 3Y | +42.63% | |
| EPS, 1Y | +68.54% | |
| EPS, 3Y | +87.77% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $22.62 | |
| SMA 200 | $21.75 | |
| SMA 200 vs Price | -3.83% | |
| SMA 50 | $21.23 | |
| SMA 50 vs Price | -6.16% | |
| Beta | 1.72 | |
| ATR | $1.49 | |
| 14-Day RSI | 46.79 | |
| 10-Day Volatility | 56.01% | |
| 1-Year Volatility | 66.43% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $771.32M | |
| EPS | -$0.17 | |
| Gross Profit | $426.83M | |
| Gross Margin | 55.34% | |
| Operating Profit | -$30.11M | |
| Operating Margin | -3.90% | |
| Net Income | -$20.39M | |
| Net Margin | -2.64% | |
| EBITDA | $15.75M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.00 | |
| Current Ratio | 2.50 | |
| Quick Ratio | 2.10 | |
| - | ||
| F-Score | 7 | |
| Altman Z-Score | 4.85 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 5,952.63 | |
| PS Ratio | 3.25 | |
| PB Ratio | 7.48 | |
| EV/EBITDA | 60.91 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $340.07M | |
| Cash & Equivalents | $254.16M | |
| Total Assets | $676.49M | |
| Current Assets | $326.05M | |
| Total Liabilities | $336.42M | |
| Current Liabilities | $130.35M | |
| Total Debt | $225.36M | |
| Short Term Debt | $20.24M | |
| Accounts Payable | $23.52M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $801.43M | |
| Operating Expenses | $456.95M | |
| Cost Of Goods Sold | $344.48M | |
| SG&A | $456.95M | |
| D&A | $45.87M | |
| Interest Expense | $0.00 | |
| Income Tax | $875.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $98.74M | |
| CFI | -$66.03M | |
| CFF | $4.96M | |
| Capex | $64.03M | |
| Free Cash Flow | $34.71M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Piper Sandler | → | |
| Stifel | → | |
| BTIG | → | |
| Telsey Advisory Group | → | |
| UBS | → | |
| Telsey Advisory Group | → | |
| BTIG | → | |
| Telsey Advisory Group | → | |
| BTIG | → | |
| Goldman Sachs | → |
Analyst sentiment
Institutional ownership
Screeners with WRBY
Data Sources & References
- WRBY Official Website www.warbyparker.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1504776/000150477625000033/0001504776-25-000033-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1504776/000150477625000010/0001504776-25-000010-index.htm
- WRBY Profile on Yahoo Finance finance.yahoo.com/quote/WRBY
- WRBY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/wrby
FAQ
What is the ticker symbol for Warby Parker Inc.?
The ticker symbol for Warby Parker Inc. is NYSE:WRBY
Does Warby Parker Inc. pay dividends?
No, Warby Parker Inc. does not pay dividends
What sector is Warby Parker Inc. in?
Warby Parker Inc. is in the Healthcare sector
What industry is Warby Parker Inc. in?
Warby Parker Inc. is in the Medical Instruments & Supplies industry
What country is Warby Parker Inc. based in?
Warby Parker Inc. is headquartered in United States
When did Warby Parker Inc. go public?
Warby Parker Inc. initial public offering (IPO) was on September 29, 2021
Is Warby Parker Inc. in the S&P 500?
No, Warby Parker Inc. is not included in the S&P 500 index
Is Warby Parker Inc. in the NASDAQ 100?
No, Warby Parker Inc. is not included in the NASDAQ 100 index
Is Warby Parker Inc. in the Dow Jones?
No, Warby Parker Inc. is not included in the Dow Jones index
When was Warby Parker Inc. last earnings report?
Warby Parker Inc.'s most recent earnings report was on November 6, 2025
When does Warby Parker Inc. report earnings?
The next expected earnings date for Warby Parker Inc. is February 26, 2026